News und Analysen
Almirall to Participate in the 41st Annual J.P. Morgan Healthcare Conference
Almirall, S.A. (ALM), a global biopharmaceutical company focused on skin health, today announced that it will participate in the upcoming 41st Annual J.P. Morgan Healthcare Conference in San
Almirall’s Nine-month 2022 Results
Almirall, S.A. (ALM), the global biopharmaceutical company based in Barcelona, has announced its 9M 2022 financial results.
Financial highlights (€ rounded million)
9M 2022
Edison Investment Research Limited: Oryzon Genomics (ORY): Planning iadademstat's path to market
Edison Investment Research Limited: Oryzon Genomics (ORY): Planning iadademstat's path to market
